German pharma benefiting from a Brexit boost? Germany consolidates itself as world leader in pharma according to the CPhI Pharma…
For LENVIMA (lenvatinib) plus KEYTRUDA (pembrolizumab) Combination Treatment as Potential First-Line Treatment of Patients with Advanced Unresectable Hepatocellular Carcinoma Not…